Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	13,591	13,089	8,234	7,125	6,824	7,635
Market Cap Growth	47.81%	58.97%	15.57%	4.41%	-10.63%	-15.23%
Enterprise Value	13,919	13,411	8,416	7,347	6,449	6,676
Last Close Price	221.88	213.24	137.67	125.95	122.13	134.53
Forward PE	42.12	94.73	-	-	-	-
PS Ratio	16.11	15.48	21.87	24.17	124.77	863.17
PB Ratio	-	-68.47	-75.24	-44.24	24.25	7.60
P/TBV Ratio	-	-	-	-	24.70	7.64
P/FCF Ratio	259.17	245.48	-	-	-	-
P/OCF Ratio	215.21	206.83	-	-	-	-
EV/Sales Ratio	16.46	15.86	22.35	24.92	117.92	754.73
EV/FCF Ratio	264.89	251.52	-	-	-	-
Debt / Equity Ratio	-5.35	-5.35	-8.10	-4.42	1.93	0.12
Debt / FCF Ratio	19.20	19.20	-	-	-	-
Net Debt / Equity Ratio	-1.57	-1.57	-2.81	-1.68	-0.89	-0.77
Net Debt / EBITDA Ratio	-1.95	-1.95	-1.08	-0.56	0.43	1.57
Net Debt / FCF Ratio	5.63	5.63	-0.97	-0.52	0.46	1.55
Asset Turnover	0.58	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.32	0.32	0.18	0.26	0.12	-
Quick Ratio	0.72	0.72	0.81	0.62	1.06	7.03
Current Ratio	1.04	1.04	1.17	0.95	1.29	8.03
Return on Equity (ROE)	-	-	-	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	-6.86%	-6.86%	-17.38%	-29.73%	-32.29%	-27.35%
Return on Capital Employed (ROCE)	-58.40%	-58.40%	-102.60%	-511.40%	-150.60%	-45.90%
Earnings Yield	-1.97%	-2.05%	-4.75%	-7.47%	-9.13%	-5.71%
FCF Yield	0.39%	0.41%	-3.87%	-7.29%	-7.99%	-6.57%
Buyback Yield / Dilution	-4.69%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q